Hi-Clearance Inc. (TPEX:1788)

Market Cap	6.05B -5.2%
Revenue (ttm)	4.28B +5.0%
Net Income	368.51M +2.5%
EPS	8.27 +2.5%
Shares Out	44.52M
PE Ratio	16.44
Forward PE	n/a
Dividend	7.00 (5.15%)
Ex-Dividend Date	Jun 23, 2025

Volume	11,259
Average Volume	20,258
Open	136.00
Previous Close	136.00
Day's Range	135.50 - 136.00
52-Week Range	135.00 - 145.00
Beta	0.10
RSI	36.68
Earnings Date	Mar 30, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2025, Hi-Clearance's revenue was 4.28 billion, an increase of 5.04% compared to the previous year's 4.07 billion. Earnings were 368.51 million, an increase of 2.45%.